Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
- Conditions
- Relapsed or Cisplatin-Refractory Germ Cell Cancer
- First Posted Date
- 2006-09-04
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 33
- Registration Number
- NCT00371553
- Locations
- 🇨🇦
Cancer Care Manitoba, Winnipeg, Manitoba, Canada
🇨🇦London Regional Cancer Centre, London, Ontario, Canada
🇨🇦QEII Health Science Center, Halifax, Nova Scotia, Canada
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
- Conditions
- Lymphoma, Non-HodgkinAdvanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Interventions
- First Posted Date
- 2006-05-11
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 150
- Registration Number
- NCT00324467
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
Acupuncture in Palliative Cancer Care
- Conditions
- NeoplasmsPalliative Care
- Interventions
- Behavioral: Nurse-led supportive careProcedure: Acupuncture
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2010-10-20
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 20
- Registration Number
- NCT00302185
- Locations
- 🇨🇦
BC Cancer Agency - Vancouver Island Centre, Victoria, British Columbia, Canada
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
- Conditions
- MelanomaLymphomaBrain NeoplasmsLung NeoplasmsColorectal Neoplasms
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 39242
- Registration Number
- NCT00207298
- Locations
- 🇨🇦
BCCA, Vancouver Centre, Vancouver, British Columbia, Canada
The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions
- Conditions
- Breast Neoplasms
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-06-27
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 100
- Registration Number
- NCT00207324
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
- Conditions
- Lung Cancer
- First Posted Date
- 2004-02-25
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- British Columbia Cancer Agency
- Registration Number
- NCT00005880
- Locations
- 🇨🇦
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2009-04-07
- Lead Sponsor
- British Columbia Cancer Agency
- Registration Number
- NCT00070083
- Locations
- 🇨🇦
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇺🇸Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers
- Conditions
- Lung CancerPrecancerous Condition
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- British Columbia Cancer Agency
- Registration Number
- NCT00061997
- Locations
- 🇨🇦
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada